• home
  • the advantage
  • about us
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • CEOs
    • portfolio
    • criteria
    • process
  • news
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • switzerland
    • new zealand
transforming inventions
into competitive advantages
Arvind Sridharan, Horizon:
"Inventages has set itself high standards - and naturally expects the same from its portfolio companies. ..."
Bernd Seizinger, Opsona:
"Inventages' strong support and expert guidance has been instrumental in transforming Opsona Therapeutics from a start-up biotech with ..."
Geoff Allison, Tanfield Foods:
"Inventages, since the outset have actively encouraged and supported our growth plans. ..."
Pierre Peteuil, Cryolog:
"Inventages invests in a long term strategy necessary for innovation. ..."
Sven Thormahlen, Mucovax:
"At Inventages people share our passion for the development of our innovative products. ..."
Holger Kunze, Accera:
"Working with Inventages has been very productive. ..."
Paul Hartung, Neuroptix:
"Inventages has been a strong supporter in realizing the Neuroptix vision. ..."
Neill Moray Mackenzie, CMP Therapeutics:
"Inventages has been extremely supportive of CMP Therapeutics since its inception. ..."
Yan Hervy, Velle Russia:
"Over the last year of cooperation, Inventages - through the very high caliber of its associates - has been able to challenge positively Velle Russia business from marketing vision to operational ..."
Graham Clarke, ImmunoBiology:
"Investment capital is of course central to create a valuable business but to be successful you need more than just funds from your investors. ..."
Wren Zhang, GC-Rise:
"GC-Rise has received great support and professional help from Inventages since the beginning. ..."
Erik van den Berg, AM-Pharma:
"Inventages has a broad network of excellent service providers and experts and can provide board room access with potential strategic partners. ..."
Jay Garnett, Steaz:
"Inventages has provided 'smart' capital to Steaz. ..."
Daniel Green, Phagenesis:
"Inventages brings talent, imagination and rigor to the process of identifying suitable investments. ..."
Barry Guld, MSI:
"The team at Inventages is the perfect partner for us. ..."

  • 2012-01-03 - Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company’s Board of Directors
    about Accera...



  • 2011-11-22 - TOPCRYO™, up in the air with LSG Sky Chefs Germany
    about CRYOLOG...



  • 2011-10-17 - Sino-UK companies announce TB vaccine partnership deal
    about ImmunoBiology...



  • 2011-10-12 - Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10
    about Shield Therapeutics...



  • 2011-10-04 - Phagenesis Closes €7 Million Series B Financing Round
    about Phagenesis...


Terms Print Top
© 2012 Inventages